IP Library Granted Patent US 11,717,392
Granted Patent B2
US 11,717,392 · App. 17/049,932 · Granted Aug 8, 2023

Modulation of inflammatory response following endovascular treatment

Inventors: Mohammed Arif Iftekhar (Irvine, CA); Peter Costandi (Irvine, CA); Carlos Ortega (Irvine, CA); Chris Williams (Irvine, CA); Craig Welk (Irvine, CA)
Assignee: Endologix LLC
A61F2/07A61F2/958A61F2002/077A61F2210/0085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,717,392
App. No.
17/049,932
Granted
Aug 8, 2023
Kind
B2
Abstract

A method of treating an aortic aneurysm of a patient with an endovascular graft system and mitigating post implant syndrome associated therewith comprises placing at least one prosthesis across an aneurysmal space. The prosthesis comprises a double-walled filling structure and a stent-graft. The stent graft is radially expanded at a first pressure and the filing structure is filled with a first filing agent to contact a thrombus in the aortic aneurysmal space. After the first filling agent is removed, the filling structure is filled with a second filling agent to contact the thrombus. Next the stent-graft is expanded at a second pressure causing the filing structure to place an effective amount of pressure on the thrombus and substantially mitigating the effects of post implant syndrome associated with the prosthesis.

Claims (29)

1. A method of treating an aortic aneurysm of a patient with an endovascular graft system and mitigating post implant syndrome inflammation resulting therefrom, comprising:

placing at least one prosthesis in an aortic aneurysmal space, said prosthesis comprising a stent-graft and a double-walled filling structure, wherein the filling structure comprises an outer wall, an inner wall, and a fillable space between the outer wall and the inner wall;

radially expanding the stent-graft with an expansion balloon at a first pressure of at least about 180 mm Hg;

filling the filling structure with a first filling agent such that the filling structure expands and contacts a thrombus disposed in the aneurysmal space;

removing the first filling agent from filling structure;

filling the filling structure with a second filling agent such that the filling structure expands and contacts the thrombus;

radially expanding the stent-graft with an expansion balloon at a second pressure thereby causing the filling structure with the second filling agent to place an effective amount of pressure on the thrombus;

wherein the effective amount of pressure placed on the thrombus mitigates the effects of post implant syndrome associated with the prosthesis by reducing inflammation in the aneurysm.

2. The method of claim 1 , further comprising the step of introducing the first filling agent into the fillable space, prior to radially expanding the stent-graft, such that the filling structure expands and contacts the thrombus disposed in the aortic aneurysmal space.

3. The method of claim 2 , comprising radially expanding the stent-graft with an expansion balloon at the second pressure thereby causing the filling structure with the first filling agent to place an effective amount of pressure between about 190 mm Hg and about 300 mm Hg, on the thrombus, wherein said second pressure is greater than the first pressure.

4. The method of claim 1 , wherein the expansion balloon is maintained in an expanded state at the first pressure for at least 30 seconds.

5. The method of claim 1 , wherein the expansion balloon is maintained in an expanded state at the second pressure for at least 30 seconds.

6. The method of claim 1 , wherein the expansion balloon is maintained in an expanded state at the first pressure, second pressure or both for about 1 minute to about 10 minutes.

7. The method of claim 1 , wherein the pressure of the expansion balloon is cycled between the first pressure and the second pressure for at least 30 seconds.

8. The method of claim 3 , wherein pressure of the expansion balloon is cycled between the first pressure and the second pressure for at least one minute.

9. The method of claim 1 , further comprising measuring, with at least one sensor, the pressure profile of the aneurysm to be treated before placement of the prosthesis.

10. The method of claim 1 , further comprising measuring, with at least one sensor, the pressure profile of the aneurysm to be treated after placing the prosthesis.

11. The method of claim 1 , further comprising measuring, with at least one sensor, the pressure profile of the aortic aneurysm to be treated and adjusting the first pressure, second pressure, or both to exceed a maximum pressure measured inside the aneurysm.

12. The method of claim 1 , wherein the filling structure comprises a channel which allows biological fluid from the thrombus or aneurysm wall to escape distally.

13. The method of claim 1 , further comprising mechanically aspirating the thrombus in the aortic aneurysmal space.

14. The method of claim 1 , further comprising delivering an agent that promotes maturation of thrombus.

15. The method of claim 1 , comprising placing an effective amount of pressure between about 190 mm Hg and about 300 mm Hg on the thrombus to displace biological fluid from the thrombus or aneurysm wall.

16. The method of claim 15 , wherein the biological fluid comprises pro-inflammatory agents.

17. The method of claim 15 , further comprising placing an effective amount of pressure on the thrombus or aneurysm wall to promote biological remodeling in the aortic aneurysmal space.

18. The method of claim 17 , wherein the biological remodeling comprises producing new fluid pathways between the aortic aneurysm space and a circulatory system of the patient.

19. The method of claim 17 , wherein the biological remodeling comprises forming new vasculature.

20. The method of claim 1 , further comprising anchoring or sealing the prosthesis proximally and distally.

21. The method of claim 1 , wherein the outer surface of the outer wall of the filling structure comprises a therapeutic agent.

22. The method of claim 1 , further comprising introducing a therapeutic agent into the aortic aneurysmal space before filling the filling structure.

Assignments (3)
SECURITY INTEREST Recorded Apr 1, 2021
From: ENDOLOGIX LLC
To: SILICON VALLEY BANK
Reel/Frame 055794/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: IFTEKHAR, MOHAMMED ARIF; COSTANDI, PETER; ORTEGA, CARLOS; WILLIAMS, CHRIS; WELK, CRAIG
To: ENDOLOGIX, INC.
Reel/Frame 054144/0558 →
CHANGE OF NAME Recorded Oct 22, 2020
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 054188/0121 →